Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer

Condition:   Oropharynx Squamous Cell Carcinoma
Interventions:   Drug: Nivolumab;   Drug: Carboplatin;   Drug: Paclitaxel;   Radiation: Radiation Therapy
Sponsors:   University of Michigan Rogel Cancer Center;   Bristol-Myers Squibb
Not yet recruiting

http://bit.ly/2HPI6iB